7 Oct 2020

Podcast: Drug Development-The Next Frontier for CDMOs?

The increasing demand for the manufacturing of highly complex biologics has driven many biotech and pharma companies to seek alliances with CDMOs. A qualified CDMO can help to understand business priorities, develop strategies to save time and costs, and provide regulatory guidance. This, in turn, means that CDMOs must have the right approach in place to fulfil high-quality requirements and have the right manufacturing technologies and capabilities in place. The complexity of CDMOs’ work will increase with new markets, demographic changes, and new demands in the clinical production of pharmaceuticals.

This podcast was originally aired as part of the CPhI Festival of Pharma.

Content provided by our supplier


  • DE
  • 2015
    On CPhI since
  • 5000+
Contract Service

Other Content from Vetter